These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35220375)

  • 1. Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
    Wang H; Fewings I; Bornman L; Shadbolt B; Fadia M; Subramaniam K
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):494-500. PubMed ID: 35220375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
    Seong G; Song JH; Kim JE; Kim TJ; Kim ER; Hong SN; Chang DK; Kim SH; Ha SY; Kim YH
    Inflamm Bowel Dis; 2023 Feb; 29(2):238-244. PubMed ID: 35396998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
    Narula N; Aruljothy A; Alshahrani AA; Fadida M; Al-Saedi M; Marshall JK; Rubin DT; Christensen B
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1676-1682. PubMed ID: 33131108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis.
    Shimodaira Y; Watanabe K; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Scand J Gastroenterol; 2022 Feb; 57(2):165-168. PubMed ID: 34663142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
    Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
    J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
    Cushing KC; Tan W; Alpers DH; Deshpande V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2020 Feb; 51(3):347-355. PubMed ID: 31696961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
    Jangi S; Yoon H; Dulai PS; Valasek M; Boland BS; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1008-1016. PubMed ID: 33119168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
    Bessissow T; Kron CM; Marcus V; Lemieux C; Laneuville J; Afif W; Wild G; Lakatos PL; Brassard P; Bitton A
    Am J Gastroenterol; 2022 Oct; 117(10):1632-1638. PubMed ID: 35862833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Yoon H; Jangi S; Dulai PS; Boland BS; Prokop LJ; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Gastroenterology; 2020 Oct; 159(4):1262-1275.e7. PubMed ID: 32585306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
    Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
    World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis.
    Nardone OM; Bazarova A; Bhandari P; Cannatelli R; Daperno M; Ferraz J; Goetz M; Gui X; Hayee B; De Hertogh G; Lazarev M; Li J; Parra-Blanco A; Pastorelli L; Panaccione R; Occhipinti V; Rath T; Smith SCL; Shivaji UN; Tontini GE; Vieth M; Villanacci V; Zardo D; Bisschops R; Kiesslich R; Ghosh S; Iacucci M
    United European Gastroenterol J; 2022 Mar; 10(2):147-159. PubMed ID: 35194978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse.
    Park J; Kang SJ; Yoon H; Park J; Oh HJ; Na HY; Lee HS; Shin CM; Park YS; Kim N; Lee DH
    Inflamm Bowel Dis; 2022 Nov; 28(11):1709-1716. PubMed ID: 35016209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
    Fron C; Pierry C; Poullenot F; Chabrun E; Subtil C; Capdepont M; Zerbib F; Belleannée G; Laharie D
    Dig Liver Dis; 2016 Jul; 48(7):734-9. PubMed ID: 27052254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Ponte A; Pinho R; Fernandes S; Rodrigues A; Alberto L; Silva JC; Silva J; Rodrigues J; Sousa M; Silva AP; Proença L; Freitas T; Leite S; Carvalho J
    Inflamm Bowel Dis; 2017 Dec; 23(12):2238-2244. PubMed ID: 28991857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.